← Back to Search

Care Coordination with Peer Support for Hepatitis C (ACCELERATE Trial)

N/A

Recruiting

Led By Matthew Akiyama, MD

Research Sponsored by Montefiore Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Chronic HCV with documented detectable viral load

18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

ACCELERATE Trial Summary

This trial will assess the feasibility of a peer-enhanced care coordination intervention for recently incarcerated individuals with HCV to promote linkage to and retention in HCV care.

Who is the study for?

This trial is for adults who have chronic Hepatitis C, were released from a NYC jail or NYS prison within the last 6 months, and can communicate in English or Spanish. They must be able to give informed consent and should not have a life expectancy of less than one year.Check my eligibility

What is being tested?

The study is testing if having a peer mentor helps people with Hepatitis C get better care after they leave jail compared to just getting the usual healthcare services. It's looking at how well this works by randomly assigning participants to either the new approach with a mentor or standard care.See study design

What are the potential side effects?

Since this trial involves social support rather than medication, there are no direct medical side effects. However, participants may experience emotional distress or discomfort when discussing their health condition with peers.

ACCELERATE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have chronic Hepatitis C with a detectable virus level.

Select...

I am 18 years old or older.

ACCELERATE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Linkage to care

Secondary outcome measures

HCV cure

HCV treatment initiation

Reinfection

+1 more

ACCELERATE Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Peer-enhanced interventionExperimental Treatment1 Intervention

Those randomized to the peer-enhanced intervention group will be contacted by a peer mentor within 72 hours of enrollment to discuss the early release period, readiness for HCV treatment, and identify ancillary needs. Individuals randomized to this arm will be provided a study cell phone.

Group II: Standard of carePlacebo Group1 Intervention

If randomized to the standard of care intervention, the participant will only receive passive referral to HCV-care.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor

441 Previous Clinical Trials

582,116 Total Patients Enrolled

2 Trials studying Hepatitis C

850 Patients Enrolled for Hepatitis C

Prisma Health-UpstateOTHER

82 Previous Clinical Trials

42,858 Total Patients Enrolled

4 Trials studying Hepatitis C

1,060 Patients Enrolled for Hepatitis C

National Institute on Drug Abuse (NIDA)NIH

2,464 Previous Clinical Trials

2,618,513 Total Patients Enrolled

46 Trials studying Hepatitis C

22,458 Patients Enrolled for Hepatitis C

Media Library

Peer mentor Clinical Trial Eligibility Overview. Trial Name: NCT04701437 — N/A

Hepatitis C Research Study Groups: Peer-enhanced intervention, Standard of care

Hepatitis C Clinical Trial 2023: Peer mentor Highlights & Side Effects. Trial Name: NCT04701437 — N/A

Peer mentor 2023 Treatment Timeline for Medical Study. Trial Name: NCT04701437 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts still ongoing for this experiment?

"Indeed, clinicaltrials.gov reveals that this medical study was initially posted on December 17th 2021 and is still recruiting patients. At present, 1 centre needs to recruit 80 volunteers for the trial."

Answered by AI

To what extent has enrollment grown for this experiment?

"Affirmative. The details on clinicaltrials.gov verify that this medical investigation is currently recruiting participants, with the initial post being made December 17th 2021 and the most recent update coming February 11th 2022. Eighty patients are needed at a single site to complete this trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants

2021. "Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04701437.